178 related articles for article (PubMed ID: 21179485)
41. The role of the VEGF-C/VEGFRs axis in tumor progression and therapy.
Chen JC; Chang YW; Hong CC; Yu YH; Su JL
Int J Mol Sci; 2012 Dec; 14(1):88-107. PubMed ID: 23344023
[TBL] [Abstract][Full Text] [Related]
42. Prognostic significance of VEGF and its receptors in endometrioid endometrial cancer.
Dobrzycka B; Terlikowski SJ; Kwiatkowski M; Garbowicz M; Kinalski M; Chyczewski L
Ginekol Pol; 2010 Jun; 81(6):422-5. PubMed ID: 20695190
[TBL] [Abstract][Full Text] [Related]
43. Differential expression of vascular endothelial growth factor A, its receptors VEGFR-1, -2, and -3 and co-receptors neuropilin-1 and -2 does not predict bevacizumab response in human astrocytomas.
Baumgarten P; Blank AE; Franz K; Hattingen E; Dunst M; Zeiner P; Hoffmann K; Bähr O; Mäder L; Goeppert B; Machein M; Seifert V; Steinbach JP; Plate KH; Harter PN; Mittelbronn M
Neuro Oncol; 2016 Feb; 18(2):173-83. PubMed ID: 26627848
[TBL] [Abstract][Full Text] [Related]
44. Angiogenic markers show high prognostic impact on survival in marginally operable non-small cell lung cancer patients treated with adjuvant radiotherapy.
Andersen S; Donnem T; Al-Saad S; Al-Shibli K; Busund LT; Bremnes RM
J Thorac Oncol; 2009 Apr; 4(4):463-71. PubMed ID: 19204576
[TBL] [Abstract][Full Text] [Related]
45. Altered expression patterns of VEGF receptors in human diabetic retina and in experimental VEGF-induced retinopathy in monkey.
Witmer AN; Blaauwgeers HG; Weich HA; Alitalo K; Vrensen GF; Schlingemann RO
Invest Ophthalmol Vis Sci; 2002 Mar; 43(3):849-57. PubMed ID: 11867607
[TBL] [Abstract][Full Text] [Related]
46. Concentration of vascular endothelial growth factor in the tumour tissue as a prognostic factor of soft tissue sarcomas.
Yudoh K; Kanamori M; Ohmori K; Yasuda T; Aoki M; Kimura T
Br J Cancer; 2001 Jun; 84(12):1610-5. PubMed ID: 11401313
[TBL] [Abstract][Full Text] [Related]
47. VEGF and VEGFR genotyping in the prediction of clinical outcome for HCC patients receiving sorafenib: the ALICE-1 study.
Scartozzi M; Faloppi L; Svegliati Baroni G; Loretelli C; Piscaglia F; Iavarone M; Toniutto P; Fava G; De Minicis S; Mandolesi A; Bianconi M; Giampieri R; Granito A; Facchetti F; Bitetto D; Marinelli S; Venerandi L; Vavassori S; Gemini S; D'Errico A; Colombo M; Bolondi L; Bearzi I; Benedetti A; Cascinu S
Int J Cancer; 2014 Sep; 135(5):1247-56. PubMed ID: 24510746
[TBL] [Abstract][Full Text] [Related]
48. Soft tissue sarcoma of extremities: the prognostic significance of adequate surgical margins in primary operation and reoperation after recurrence.
Liu CY; Yen CC; Chen WM; Chen TH; Chen PC; Wu HT; Shiau CY; Wu YC; Liu CL; Tzeng CH
Ann Surg Oncol; 2010 Aug; 17(8):2102-11. PubMed ID: 20217247
[TBL] [Abstract][Full Text] [Related]
49. Vascular endothelial growth factor and soft tissue sarcomas: tumor expression correlates with grade.
Chao C; Al-Saleem T; Brooks JJ; Rogatko A; Kraybill WG; Eisenberg B
Ann Surg Oncol; 2001 Apr; 8(3):260-7. PubMed ID: 11314944
[TBL] [Abstract][Full Text] [Related]
50. [Expression and clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in non-small cell lung carcinoma].
Lu ZQ; Li HG; Xie DR; Zhang HZ; Shen XM; Zeng YJ; Zeng H
Ai Zheng; 2005 Sep; 24(9):1132-5. PubMed ID: 16159440
[TBL] [Abstract][Full Text] [Related]
51. Serum vascular endothelial growth factor A and vascular endothelial growth factor receptor 2 as prognostic biomarkers for uterine cervical cancer.
Sawada M; Oishi T; Komatsu H; Sato S; Chikumi J; Nonaka M; Kudoh A; Osaku D; Harada T
Int J Clin Oncol; 2019 Dec; 24(12):1612-1619. PubMed ID: 31236742
[TBL] [Abstract][Full Text] [Related]
52. VEGFR endocytosis: Implications for angiogenesis.
Saikia Q; Reeve H; Alzahrani A; Critchley WR; Zeqiraj E; Divan A; Harrison MA; Ponnambalam S
Prog Mol Biol Transl Sci; 2023; 194():109-139. PubMed ID: 36631189
[TBL] [Abstract][Full Text] [Related]
53. Expression and predictive value of lymph-specific markers in urothelial carcinoma of the bladder.
von Hardenberg J; Martini T; Knauer A; Ströbel P; Becker A; Herrmann E; Schubert C; Steidler A; Bolenz C
Urol Oncol; 2014 Jan; 32(1):54.e9-17. PubMed ID: 24360666
[TBL] [Abstract][Full Text] [Related]
54. The evaluation of circulating endothelial progenitor cells and related angiogenic markers as prognostic factors in soft-tissue tumors.
Karampinis I; Joas E; Dreyer A; Ronellenfitsch U; Jakob J; Hohenberger P; Nowak K
Eur J Surg Oncol; 2018 Apr; 44(4):496-501. PubMed ID: 29397265
[TBL] [Abstract][Full Text] [Related]
55. The prognostic value of vascular endothelial growth factor (VEGF)-A and its receptor in clinically localized prostate cancer: a prospective evaluation in 100 patients undergoing radical prostatectomy.
Mao K; Badoual C; Camparo P; Delongchamps NB; Vieillefond A; Dinh-Xuan AT; Peyromaure M
Can J Urol; 2008 Oct; 15(5):4257-62. PubMed ID: 18814815
[TBL] [Abstract][Full Text] [Related]
56. Expression of vascular endothelial growth factor receptors 1, 2, and 3 in quiescent endothelia.
Witmer AN; Dai J; Weich HA; Vrensen GF; Schlingemann RO
J Histochem Cytochem; 2002 Jun; 50(6):767-77. PubMed ID: 12019293
[TBL] [Abstract][Full Text] [Related]
57. [Expression of vascular endothelial growth factors (VEGF)-A, -C and -D and their prognostic significance and relationship with angio- and lymphangiogenesis in gastric cancer].
Wang XL; Ai ZS; Fang JP; Tang RY; Chen XM
Zhonghua Zhong Liu Za Zhi; 2008 Nov; 30(11):837-43. PubMed ID: 19173829
[TBL] [Abstract][Full Text] [Related]
58. Expression and localization of VEGF receptors in human fetal skeletal tissues.
Marini M; Sarchielli E; Toce M; Acocella A; Bertolai R; Ciulli C; Orlando C; Sgambati E; Vannelli GB
Histol Histopathol; 2012 Dec; 27(12):1579-87. PubMed ID: 23059888
[TBL] [Abstract][Full Text] [Related]
59. Prognostic implications of PD-L1 expression in patients with soft tissue sarcoma.
Kim C; Kim EK; Jung H; Chon HJ; Han JW; Shin KH; Hu H; Kim KS; Choi YD; Kim S; Lee YH; Suh JS; Ahn JB; Chung HC; Noh SH; Rha SY; Kim SH; Kim HS
BMC Cancer; 2016 Jul; 16():434. PubMed ID: 27393385
[TBL] [Abstract][Full Text] [Related]
60. Differential effects of the vascular endothelial growth factor receptor inhibitor PTK787/ZK222584 on tumor angiogenesis and tumor lymphangiogenesis.
Schomber T; Zumsteg A; Strittmatter K; Crnic I; Antoniadis H; Littlewood-Evans A; Wood J; Christofori G
Mol Cancer Ther; 2009 Jan; 8(1):55-63. PubMed ID: 19139113
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
